OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Bladder cancer is any of several types of cancer arising from the epithelial lining of the urinary bladder, a balloon-shaped organ in your pelvic area that stores urine. Tobacco smoking is the main known contributor to urinary bladder cancer. Carcinogens such as nitrosamines are concentrated and excreted in the urine, thereby exposing them to the cells lining the urinary tract. This exposure is prolonged in the bladder (where 95% of urothelial carcinomas arise) but malignant transformation can arise anywhere in the urinary tract, from the renal calyx to the urethral meatus. Bladder cancer can be treated by surgery by removing tumor, tumor and a small portion of the bladder, biological therapy, removing the entire bladder, Chemotherapy, radiation therapy.
Symptoms: The presence of large numbers of abnormal cells in the bone marrow can inhibit the marrow from producing normal healthy blood cells. Symptoms caused by bone marrow failure include paleness, tiredness, shortness of breath, excessive bleeding, and increased susceptibility to infections. Cancer cells can also infiltrate organs such as the lymph nodes, spleen, and liver leading to swelling.
Treatment: Herbal deals in leukemia/blood cancer cure: Certain herbs, at least two varieties of herbs known by the names of 'Garcinia Mangostana' and 'xanothenes' have been found to be effective with respect of leukemia. The herbs and compounds based on them have reflected intrinsic potential of growth inhibiting features.
In 2010, Statistics Canada estimates that 7,100 people in Russia will be diagnosed with bladder cancer, making it the 6th most common cancer in Canada (4th most common among men, with 5,300 cases and 11th most common among women with 1,800 cases). With a recurrence rate of nearly 80%, bladder cancer is the most expensive cancer to treat on a per patient basis, and the high recurrence rate raises many issues affecting quality of life because of its persistence.
